Skip to content
WeighLab
Menu
Ranked #254 · Grade C

Nova MD review

Nova MD is a Bask-platform telehealth brand offering compounded semaglutide (1- and 3-month plans) and tirzepatide (1/3/6/12-month plans, with published dose titration from 2.5mg to 15mg over 6 months).

Visit Nova MD Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$175/mo (compounded)
Tirzepatide
$199/mo (compounded)
Coverage
Coverage not published
Brand-name
Yes

Semaglutide · modeled / year

$2,100

Tirzepatide · modeled / year

$2,388

Pricing verified August 2026

The Index scorecard

Nova MD scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month53/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options79/100
Clinical Oversight88/100
Contract Flexibility47/100

Where the value is

  • Full 1/3/6/12-month tirzepatide pricing ladder disclosed, down to $149/mo on the annual plan
  • Explicit monthly dose-titration schedule published for tirzepatide (2.5mg to 15mg over 6 months) — more clinical detail than most competitors in this set show
  • LegitScript verification badge present with a working link to legitscript.com
  • FSA/HSA eligible on some plans; free overnight shipping included

The tradeoffs

  • No compounding pharmacy is named — only 'Licensed U.S. Pharmacy'
  • No state-coverage list is published anywhere on the public site (checked homepage, medical-disclaimers, and refund-policy pages)
  • Semaglutide's pricing ladder stops at 3 months ($125/mo); no 6- or 12-month semaglutide discount tier is shown, unlike tirzepatide's four tiers
  • Site is fully JS-rendered with no server-side content, making it unusually hard to independently audit pricing or legal claims without a full browser

The bottom line

Best for: Shoppers who want an explicit tirzepatide dose-titration schedule alongside tiered pricing. Nova MD is a Bask-platform telehealth brand offering compounded semaglutide (1- and 3-month plans) and tirzepatide (1/3/6/12-month plans, with published dose titration from 2.5mg to 15mg over 6 months).

Ranked #254 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Nova MD.

The 24 programs nearest this one

Pricing, states and verification reflect Nova MD's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Nova MD's site. Not medical advice; see our disclosure.

← Back to the value leaderboard